Skip to main content

Caredx

CareDx Inc is an American precision medicine company specializing in transplant patient genomics and diagnostic monitoring solutions. The company provides molecular diagnostic tests, donor-derived cell-free DNA assays, HLA typing reagents, and digital health software including AlloMap and AlloSure. Main revenue drivers consist of testing service fees for organ transplant surveillance billed to insurance providers and health systems alongside laboratory product sales. CareDx serves transplant cardiologists, nephrologists, clinical laboratories, transplant centers, and organ recipient patients across North America and Europe. The company holds a market-leading position in genomics-based transplant patient care and post-transplant monitoring. Headquartered in South San Francisco, California, CareDx Inc is listed on the Nasdaq Stock Market.

4 of the funds FundTelligence covers report a position in Caredx.

Legal name
CAREDX
Sector
Health Care
Country
United States
Funds holding it
4
Exposure themes
Molecular Diagnostics, Precision Medicine & Genomics, Transplant Diagnostics

Funds holding Caredx

Loading...